Cholesterol-Lowering Agents.

Rosenson, Robert S; Hegele, Robert A; Koenig, Wolfgang

Rosenson, Robert S; Hegele, Robert A; Koenig, Wolfgang.

Affiliation

Rosenson RS; From the Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY (R.S.R.).
Hegele RA; Department of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada.
Koenig W; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany (W.K.).

Circ Res ; 124(3): 364-385, 2019 02.

Article in En | MEDLINE | ID: mdl-30702994

Subject(s)

Atherosclerosis/drug therapy; Cardiovascular Diseases/prevention & control; Cholesterol, LDL/blood; PCSK9 Inhibitors; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents/therapeutic use; Atherosclerosis/etiology; Cardiovascular Diseases/etiology; Clinical Trials as Topic; Diabetes Mellitus, Type 2/complications; HIV Infections/complications; Humans; Hyperlipoproteinemia Type II/drug therapy; Lipoproteins/metabolism; Mutation; Proprotein Convertase 9/genetics; Proprotein Convertase 9/physiology; Renal Insufficiency, Chronic/complications

Key words

cardiovascular disease; cholesterol; myocardial infarction; patients; subtilisin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Atherosclerosis / PCSK9 Inhibitors / Cholesterol, LDL Type of study: Etiology_studies / Guideline / Systematic_reviews Limits: Humans Language: En Journal: Circ Res Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google